Cargando…

Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This study was supported by Netherlands Organization for Health Research and Development BACKGROUND: Myeloperoxidase (MPO), an enzyme most abundantly expressed by neutrophils, is increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Shama, R F M, Ernault, A C C, Meulendijks, E R, Fabrizi, B, Van Amersfoorth, S C M, Boender, A R, Coronel, R, Boukens, B J D, De Groot, J R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207031/
http://dx.doi.org/10.1093/europace/euad122.016
_version_ 1785046358837690368
author Al-Shama, R F M
Ernault, A C C
Meulendijks, E R
Fabrizi, B
Van Amersfoorth, S C M
Boender, A R
Coronel, R
Boukens, B J D
De Groot, J R
author_facet Al-Shama, R F M
Ernault, A C C
Meulendijks, E R
Fabrizi, B
Van Amersfoorth, S C M
Boender, A R
Coronel, R
Boukens, B J D
De Groot, J R
author_sort Al-Shama, R F M
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This study was supported by Netherlands Organization for Health Research and Development BACKGROUND: Myeloperoxidase (MPO), an enzyme most abundantly expressed by neutrophils, is increased in the atrial tissue of AF patients and is associated with treatment failure. Moreover, MPO increases fibrosis and AF susceptibility in mouse atria. However, how MPO promotes AF has yet to be fully established. PURPOSE: To investigate the role of MPO in electrophysiological and structural remodelling. METHODS: We incubated cultured neonatal rat ventricular myocyte (NRVM) monolayers with 1 μg/mL MPO or vehicle for 24 hours. We then performed electrophysiological mapping using an 8x8 multielectrode array (MEA) setup with 100 μm-sized electrodes and 700 μm inter-electrode distance (n=8 MPO, n=7 control) and recorded action potentials (AP) using a microelectrode during pacing. Additionally, we quantified the number of fibroblasts using vimentin staining (n=5/group) and the expression of extracellular matrix (ECM) genes (COL1A1, COL8A2, FN1, CTGF, TNC, THBS2, MMP2, MMP12) using qPCR (n=4/group). Multielectrode data were analyzed with custom-made software in MATLAB. Statistical analysis was performed in R. Data presented as median [interquartile range]. RESULTS: NRVM monolayers incubated with MPO were unresponsive to pacing (5/8 vs 0/7 control) or had a higher pacing threshold (1300 [1000-2500] vs 500 [400-600] μA) (p=0.02). The percent of excitable tissue was lower in the MPO than in the control group, and the propagation of spontaneous activations was slower and more heterogeneous (index: 5 [3.6-9.5] vs 2 [1.5-3], p=0.004). More fractionated electrograms were present in MPO than in the control (29 [25-40] vs 11 [4-23] electrodes per grid, p=0.02). Re-entry was observed in 3/8 MPO-incubated monolayers vs 0/7 controls. Intracellular recordings revealed a less negative resting membrane potential (-50 [-24- -52] vs -69 [-56- -79] mV, p=0.04) and lower AP upstroke velocity (4 [2.5-14] vs 26 [22-28] V/s, p=0.01) in MPO-incubated cardiomyocytes than in the control. Moreover, relative to the control, MPO significantly increased the number of fibroblasts (126 [120-128] vs 87 [70-106] cells/0.26 mm^2, p=0.02) and the expression of MMP12 (1.17 (fold-change), p=0.04), whereas a trend toward increase was observed for other ECM genes, such as COL8A2 (1.5 (fold change), p=0.1). CONCLUSION: Incubation of NVRM with MPO results in depolarization of cardiomyocytes and an increase in the number of fibroblasts and ECM gene expression. Thereby, MPO increases conduction heterogeneity and susceptibility to re-entry. [Figure: see text] [Figure: see text]
format Online
Article
Text
id pubmed-10207031
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102070312023-05-25 Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers Al-Shama, R F M Ernault, A C C Meulendijks, E R Fabrizi, B Van Amersfoorth, S C M Boender, A R Coronel, R Boukens, B J D De Groot, J R Europace 10.1.99 - Pathophysiology and Mechanisms, Other FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This study was supported by Netherlands Organization for Health Research and Development BACKGROUND: Myeloperoxidase (MPO), an enzyme most abundantly expressed by neutrophils, is increased in the atrial tissue of AF patients and is associated with treatment failure. Moreover, MPO increases fibrosis and AF susceptibility in mouse atria. However, how MPO promotes AF has yet to be fully established. PURPOSE: To investigate the role of MPO in electrophysiological and structural remodelling. METHODS: We incubated cultured neonatal rat ventricular myocyte (NRVM) monolayers with 1 μg/mL MPO or vehicle for 24 hours. We then performed electrophysiological mapping using an 8x8 multielectrode array (MEA) setup with 100 μm-sized electrodes and 700 μm inter-electrode distance (n=8 MPO, n=7 control) and recorded action potentials (AP) using a microelectrode during pacing. Additionally, we quantified the number of fibroblasts using vimentin staining (n=5/group) and the expression of extracellular matrix (ECM) genes (COL1A1, COL8A2, FN1, CTGF, TNC, THBS2, MMP2, MMP12) using qPCR (n=4/group). Multielectrode data were analyzed with custom-made software in MATLAB. Statistical analysis was performed in R. Data presented as median [interquartile range]. RESULTS: NRVM monolayers incubated with MPO were unresponsive to pacing (5/8 vs 0/7 control) or had a higher pacing threshold (1300 [1000-2500] vs 500 [400-600] μA) (p=0.02). The percent of excitable tissue was lower in the MPO than in the control group, and the propagation of spontaneous activations was slower and more heterogeneous (index: 5 [3.6-9.5] vs 2 [1.5-3], p=0.004). More fractionated electrograms were present in MPO than in the control (29 [25-40] vs 11 [4-23] electrodes per grid, p=0.02). Re-entry was observed in 3/8 MPO-incubated monolayers vs 0/7 controls. Intracellular recordings revealed a less negative resting membrane potential (-50 [-24- -52] vs -69 [-56- -79] mV, p=0.04) and lower AP upstroke velocity (4 [2.5-14] vs 26 [22-28] V/s, p=0.01) in MPO-incubated cardiomyocytes than in the control. Moreover, relative to the control, MPO significantly increased the number of fibroblasts (126 [120-128] vs 87 [70-106] cells/0.26 mm^2, p=0.02) and the expression of MMP12 (1.17 (fold-change), p=0.04), whereas a trend toward increase was observed for other ECM genes, such as COL8A2 (1.5 (fold change), p=0.1). CONCLUSION: Incubation of NVRM with MPO results in depolarization of cardiomyocytes and an increase in the number of fibroblasts and ECM gene expression. Thereby, MPO increases conduction heterogeneity and susceptibility to re-entry. [Figure: see text] [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207031/ http://dx.doi.org/10.1093/europace/euad122.016 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 10.1.99 - Pathophysiology and Mechanisms, Other
Al-Shama, R F M
Ernault, A C C
Meulendijks, E R
Fabrizi, B
Van Amersfoorth, S C M
Boender, A R
Coronel, R
Boukens, B J D
De Groot, J R
Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers
title Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers
title_full Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers
title_fullStr Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers
title_full_unstemmed Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers
title_short Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers
title_sort myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers
topic 10.1.99 - Pathophysiology and Mechanisms, Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207031/
http://dx.doi.org/10.1093/europace/euad122.016
work_keys_str_mv AT alshamarfm myeloperoxidasecausesbotharrhythmogenicstructuralandelectricalremodellinginneonatalratventricularmyocytemonolayers
AT ernaultacc myeloperoxidasecausesbotharrhythmogenicstructuralandelectricalremodellinginneonatalratventricularmyocytemonolayers
AT meulendijkser myeloperoxidasecausesbotharrhythmogenicstructuralandelectricalremodellinginneonatalratventricularmyocytemonolayers
AT fabrizib myeloperoxidasecausesbotharrhythmogenicstructuralandelectricalremodellinginneonatalratventricularmyocytemonolayers
AT vanamersfoorthscm myeloperoxidasecausesbotharrhythmogenicstructuralandelectricalremodellinginneonatalratventricularmyocytemonolayers
AT boenderar myeloperoxidasecausesbotharrhythmogenicstructuralandelectricalremodellinginneonatalratventricularmyocytemonolayers
AT coronelr myeloperoxidasecausesbotharrhythmogenicstructuralandelectricalremodellinginneonatalratventricularmyocytemonolayers
AT boukensbjd myeloperoxidasecausesbotharrhythmogenicstructuralandelectricalremodellinginneonatalratventricularmyocytemonolayers
AT degrootjr myeloperoxidasecausesbotharrhythmogenicstructuralandelectricalremodellinginneonatalratventricularmyocytemonolayers